Supreme Court to decide who’s liable for faulty generic drugs

The Supreme Court heard oral arguments on Tuesday about who is liable for a faulty generic drug.

A woman who took a pain killer ended up losing much of her skin, had to be put in a drug-induced coma and is now blind. The manufacturer says they are not liable because they make the drug exactly as the brand manufacturer did and the FDA approved it.

Host Carmen Russell-Sluchansky spoke with Andre M. Mura, litigation counsel for the Center for Constitutional Litigation, to discuss the case.


About Carmen Munir Russell-Sluchansky 360 Articles
Carmen is a multimedia journalist based in Washington, DC whose work has appeared in a variety of outlets including National Geographic, NBC News, the BBC, Asia! Magazine, The China Post, Chicago Tribune and Orlando Sentinel.